Lessee, Operating Lease, Liability, to be Paid, Year Two of China SXT Pharmaceuticals, Inc. from 30 Sep 2024 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
China SXT Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 30 Sep 2024 to 31 Mar 2025.
  • China SXT Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Mar 2025 was $68,957.
China SXT Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in CNY history and change rate from 30 Sep 2024 to 31 Mar 2025.
  • China SXT Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Mar 2025 was ¥500,400.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (CNY)

China SXT Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $68,957 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q3 2024 $71,306 30 Sep 2024 6-K 28 Mar 2025 2025 Q2

China SXT Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 ¥500,400 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q3 2024 ¥500,400 30 Sep 2024 6-K 28 Mar 2025 2025 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.